 |
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Sunday, November 8, 2009
|
|
|
NetWellness provides the highest quality health information and education services created and evaluated by faculty of our partner universities.
Sunday, November 8, 2009
|
Lung Transplantation |
Alpha-1 antitrypsin and lung transplant06/13/2009 |
If an individuak has alpha-1 antitrypsin deficiency and gets a lung transplant doe thy still take the weekly injections of alpha-1 protenase inhibitor
Among lung transplant experts there is no clear consensus regarding the need for continuation of alpha-1-proteinase inhibitor infusions following lung transplantation. While in the body there remains an excess of proteinases with respect to proteinase inhibitors following transplantation and thus a theoretical benefit to continuing such proteinase inhibitor infusions, there is no compelling evidence that the transplanted lung suffers injury from not continuing these infusions.
What is likely more important than the continued infusion of proteinase inhibitor is the abstinence of cigarette smoking, which clearly "tips the balance" in favor of the injurious proteinases. Because of this lack of consensus, some lung transplant programs have recommended continuation of the proteinase inhibitor infusions while other programs have not.
|
David R. Nunley, MD, FCCP Associate Professor of Clinical Medicine Pulmonary, Allergy, Critical Care & Sleep Medicine Department of Internal Medicine College of Medicine The Ohio State University |
|
|
|
Please note: only your personal physician or other health professional you consult can best advise you on matters of your health based on your medical history, your family medical history, your medication history, and how information from any of these databases may apply to you. Neither University of Cincinnati (NetWellness) nor any party involved in creating, producing or delivering this web site shall be liable for any damages arising out of access to or use of this web site, or any errors or omissions in the content thereof. (More) 
|